Keywords: aricept, benefit, patients, severe, ad, results, international

Aricept of benefit to patients with severe AD

Article | 13 August 2007

Print This

The results of an international study, published in the July 31 edition of the journal Neurology, indicates that Japanese drugmaker Eisai's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in